Articles from HemoSonics LLC

HemoSonics LLC, a medical device company focused on acute bleeding management, today announced that its Quantra® Hemostasis System for Obstetric Procedures is one of the top three finalists in the Women’s Health and Reproductive Innovations category of the world-renowned 2026 Edison Awards. The Company’s point-of-care solution received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded use of its Quantra Hemostasis System with QStat® Cartridge in peripartum obstetric procedures in September 2025. The Quantra System is the first and only FDA-cleared viscoelastic testing (VET) platform for obstetric bleeding. By providing clinicians with actionable data, the Quantra Hemostasis System delivers fast, real-time coagulation insights at the point of need, helping protect women at risk of peripartum hemorrhage.